Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Reviva Pharmaceuticals Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Reviva Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Reviva Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Reviva Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Reviva Pharmaceuticals Inc.'s pipeline products Reasons to buy - Evaluate Reviva Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Reviva Pharmaceuticals Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Reviva Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Reviva Pharmaceuticals Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Reviva Pharmaceuticals Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Reviva Pharmaceuticals Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Reviva Pharmaceuticals Inc. Snapshot 5 Reviva Pharmaceuticals Inc. Overview 5 Key Information 5 Key Facts 5 Reviva Pharmaceuticals Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Reviva Pharmaceuticals Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Reviva Pharmaceuticals Inc. - Pipeline Products Glance 11 Reviva Pharmaceuticals Inc. - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Reviva Pharmaceuticals Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Reviva Pharmaceuticals Inc. - Unknown Stage Pipeline Products 14 Unknown Products/Combination Treatment Modalities 14 Reviva Pharmaceuticals Inc. - Drug Profiles 15 RP-5063 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 RP-10000 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 RP-11000 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RP-12000 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 RP-13000 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 RP-14000 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 RP-15000 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 RP-16000 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 RP-17000 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Reviva Pharmaceuticals Inc. - Pipeline Analysis 24 Reviva Pharmaceuticals Inc. - Pipeline Products by Target 24 Reviva Pharmaceuticals Inc. - Pipeline Products by Route of Administration 25 Reviva Pharmaceuticals Inc. - Pipeline Products by Molecule Type 26 Reviva Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 27 Reviva Pharmaceuticals Inc. - Recent Pipeline Updates 28 Reviva Pharmaceuticals Inc. - Dormant Projects 30 Reviva Pharmaceuticals Inc. - Locations And Subsidiaries 31 Head Office 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 33 Disclaimer 33
List of Tables Reviva Pharmaceuticals Inc., Key Information 5 Reviva Pharmaceuticals Inc., Key Facts 5 Reviva Pharmaceuticals Inc. - Pipeline by Indication, 2014 8 Reviva Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 9 Reviva Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 10 Reviva Pharmaceuticals Inc. - Phase III, 2014 11 Reviva Pharmaceuticals Inc. - Preclinical, 2014 12 Reviva Pharmaceuticals Inc. - Discovery, 2014 13 Reviva Pharmaceuticals Inc. - Unknown, 2014 14 Reviva Pharmaceuticals Inc. - Pipeline by Target, 2014 24 Reviva Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 25 Reviva Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 26 Reviva Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 27 Reviva Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 28 Reviva Pharmaceuticals Inc. - Dormant Developmental Projects,2014 30
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.